Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. - Wikidata - awgldk - TriplyDB

Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination.

Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination.

http://www.wikidata.org/entity/Q37603557

about

Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens Synthetic Nanoparticles for Vaccines and Immunotherapy Engineering New Approaches to Cancer Vaccines Intravital Microscopy Imaging Approaches for Image-Guided Drug Delivery Systems Towards programming immune tolerance through geometric manipulation of phosphatidylserine.Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination Biomaterials for nanoparticle vaccine delivery systems.Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization.Whole-animal imaging and flow cytometric techniques for analysis of antigen-specific CD8+ T cell responses after nanoparticle vaccination.Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice.Supramolecular peptide vaccines: tuning adaptive immunity.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation Beyond antigens and adjuvants: formulating future vaccines.Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.Biomaterial Strategies for Immunomodulation.Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells.Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.A Distinct Lung-Interstitium-Resident Memory CD8(+) T Cell Subset Confers Enhanced Protection to Lower Respiratory Tract Infection Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.HYDROGEL-BASED NANOCOMPOSITES OF THERAPEUTIC PROTEINS FOR TISSUE REPAIR.Designer vaccine nanodiscs for personalized cancer immunotherapy.Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine.Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.Vaccine nanoparticles for protection against HIV infection.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Engineering immunity in the mucosal niche against sexually transmitted infections.Nanotechnology for protein delivery: Overview and perspectives.Design of nanomaterial based systems for novel vaccine development.Biomaterials for enhancing anti-cancer immunity.Biomaterial strategies for generating therapeutic immune responses.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Eliciting Epitope-Specific CD8+ T Cell Response by Immunization with Microbial Protein Antigens Formulated with α-Galactosylceramide: Theory, Practice, and Protocols.Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity.

P2860

Q26784233-7D915EF5-BB8A-4757-A6CF-CD712F79225E Q27011190-7E7CCC15-6836-43D0-AAAF-740BA1DD0637 Q27310007-A38E7F0A-D7EB-4018-AD14-C1C7E58DA3F9 Q28085375-0128C6B6-CD2A-42BA-8C45-EF6ECD5C2E7D Q28085563-972A1536-76C7-4CD6-9B9B-D034498CA9F6 Q28553638-CBB1E518-85A3-48DC-9B84-4E90CAC83355 Q30751004-00FB8575-F454-42F9-871F-FCC996B0A057 Q33920298-72DDF2F2-17E6-4971-A196-B18CC378CE67 Q34074750-4902BAB6-0EE3-4DD7-A4D2-C920ABB2DA27 Q34345012-23E1AD34-F0AD-449F-960B-4BE01E034C50 Q34985692-D6583841-0A50-4122-AC4D-3CC7C99BE3EC Q35970758-76D7A0E8-1A7A-48EE-8B44-0BD17743883E Q36099185-A600F249-C3A9-4902-A731-8BB66A40F7AE Q36175673-7A42D796-06A0-4DB1-84E5-2947F6A5AC2F Q36598433-2816F49F-6CF7-4BE3-A29A-771070ABAFFB Q36618500-F8F98420-8F06-4AAC-AA19-9CA26682F2FA Q36638606-14B0BD48-7F12-4F12-966C-1E26782EF638 Q36684345-C8039196-AA3D-412C-A4A2-D4EB33E8729E Q36703124-3EEC048F-6B4C-4295-A873-00D320AA611D Q36821628-E4B1130A-319D-4520-930B-2B78F95AD007 Q36822999-747A7FFE-31A5-4C7A-9B79-CE854BCE764F Q36978334-57FC0B24-45E4-4D56-A53B-737606EF33A9 Q37253257-40FF9437-8617-44F1-9DC1-5A73F518E4D7 Q37377550-FCFF2CFA-5955-4B81-B1BF-3623A80C72CE Q37723894-726AD187-6B1C-490C-89AE-16F002472047 Q37730767-E128DB87-BFD0-419A-835A-911BF1DB42D2 Q37736868-3ECF91AA-E892-48B5-A4C8-C762EEAFF485 Q37740679-1A9FB536-CFFF-4B5F-AAEE-2273244A8D10 Q38195597-BD4F8B43-A488-48EA-8C2A-90FE5337B7E8 Q38297557-7849EEFC-A82E-4F1B-88B5-98355ACF0F9C Q38405327-DD133F75-58F1-467C-9104-C6A5C1776E77 Q38418305-682D062C-EF00-4225-BDBB-3F9F1C9E1563 Q38543768-F4E95D42-7540-46C7-9C41-AFFCFEB5B4C3 Q38605185-4644337B-EF25-49C2-BF03-960556809470 Q38739675-3B5D9B30-C529-4FED-9C1D-358E1D3F443C Q38741829-65D60F9E-313E-43AB-8727-E7D88B539FFB Q39271088-4BD292ED-5B43-48E0-8E3F-3EE9D63C612B Q39450802-C0A9F030-F303-4194-B7E6-7A4A45850F88 Q40513167-9C9B0B79-8F7E-4643-B181-1A9AAEC87BB9 Q47203993-88D9A29A-A9E8-41F5-A806-DF74E9D758B2

P2860

Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination.

http://www.wikidata.org/entity/Q37603557

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Generation of effector memory ...... nary nanoparticle vaccination.

@en

Generation of effector memory ...... nary nanoparticle vaccination.

@nl

type

label

Generation of effector memory ...... nary nanoparticle vaccination.

@en

Generation of effector memory ...... nary nanoparticle vaccination.

@nl

prefLabel

Generation of effector memory ...... nary nanoparticle vaccination.

@en

Generation of effector memory ...... nary nanoparticle vaccination.

@nl

P1433

Q37603557-FF856C5A-0DD4-401D-A5E3-4C95D52F5E1D

P1476

Q37603557-0268808C-EE34-4868-AA55-A2DCC0267B18

P2093

Q37603557-14A14C38-A0FE-4ED7-BCB6-5AC4CBA89173

Q37603557-220920EE-D984-47D3-80D5-CE6E340C873A

Q37603557-7EA8CA17-643D-4902-B4B4-CFFA0B2FD051

Q37603557-827FDB3C-E503-431B-9655-B89C6A87E184

Q37603557-B0F1E5F4-FEBD-4B76-AE60-FA9AF6698604

Q37603557-B8CCC641-8AAF-44E9-B760-435D9B08FC24

Q37603557-D04616B6-585B-4AED-8BD4-6BF667E84320

Q37603557-DF06FD0F-B130-49F6-A2BE-30E1DBE377A8

Q37603557-ECFB94E0-F1DE-4FE5-AD5A-841843D48C34

Q37603557-EFA3D90C-EE39-4AF0-84EE-28306F15C49D

P2860

Q37603557-09026A50-E9A4-49EB-B886-500E839483BD

Q37603557-17A424DC-A4F0-45AD-9C47-63874A56AAC3

Q37603557-1AC7D58C-33F8-4061-BAD0-AA5FA66EC149

Q37603557-1C5B029F-2475-4220-B805-87EAC3EC686F

Q37603557-261E5127-49D5-4A86-939B-78FD269554CC

Q37603557-2CCD09DC-381F-4D87-BF0E-EF9060051E7F

Q37603557-2FED930F-915D-4B0C-90A6-6A056DF8565C

Q37603557-419C4FD2-C886-4E3D-B510-C5A3797F1BEE

Q37603557-42369370-54DF-4CD0-A036-9141E5F56215

Q37603557-43B5F2D5-E521-45FE-BA2B-6D2246B53A4B

P304

Q37603557-CD6D011B-928A-4F2D-8988-DC43B842EF27

P31

Q37603557-ACAE3779-7A79-402F-AA59-846A966A5C03

P356

Q37603557-83FB81D3-C5E7-4FF8-8ED9-596571494797

P407

Q37603557-07C4AF02-A281-4308-BF87-B415D0189CDA

P433

Q37603557-48A50541-1BF9-422F-A825-9669AE044EDA

P478

Q37603557-9CCF95EF-228E-4175-BE0C-A2D02FCAFA79

P50

Q37603557-125E729F-D97C-4765-A4CE-2BE9FFE607B3

P577

Q37603557-01860991-FA2E-40B6-9623-BA3C8CD37514

P5875

Q37603557-D42C6437-B311-4F74-A693-3F7509007D18

P698

Q37603557-A90F2C19-9A5D-42CE-8880-C82B4E9DD779

P921

Q37603557-EFBB842E-04A2-401A-AF84-2AB9E5D9FE8B

P932

Q37603557-01763FFE-EC5B-4E68-9EF0-182528811F7A

P356

SCITRANSLMED.3006516

P1433

Science Translational Medicine

P1476

Generation of effector memory ...... nary nanoparticle vaccination.

@en

P2093

Adrienne V Li

http://www.w3.org/2001/XMLSchema#string

Dan H Barouch

http://www.w3.org/2001/XMLSchema#string

Darrell J Irvine

http://www.w3.org/2001/XMLSchema#string

Eung-Jun Im

http://www.w3.org/2001/XMLSchema#string

Heikyung Suh

http://www.w3.org/2001/XMLSchema#string

Jamal Elkhader

http://www.w3.org/2001/XMLSchema#string

James J Moon

http://www.w3.org/2001/XMLSchema#string

Maria H Foley

http://www.w3.org/2001/XMLSchema#string

Minmin Yen

http://www.w3.org/2001/XMLSchema#string

Wuhbet Abraham

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response

Central memory and effector memory T cell subsets: function, generation, and maintenance

Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.

Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic.

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase

Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung

Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

Memory CD8+ T cell differentiation

Initial T cell frequency dictates memory CD8+ T cell lineage commitment.

Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors

P304

204ra130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3006516

http://www.w3.org/2001/XMLSchema#string

P407

P433

204

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Michael A Seidman

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257074941

http://www.w3.org/2001/XMLSchema#string

P698

24068737

http://www.w3.org/2001/XMLSchema#string

P921

P932

3934930

http://www.w3.org/2001/XMLSchema#string